{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T03:16:16Z","timestamp":1784949376300,"version":"3.55.0"},"reference-count":153,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005317","name":"Kermanshah University of Medical Sciences","doi-asserted-by":"publisher","award":["4040262"],"award-info":[{"award-number":["4040262"]}],"id":[{"id":"10.13039\/501100005317","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-025-03069-6","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T03:57:54Z","timestamp":1763438274000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["3D bioprinting innovations: a new frontier in breast cancer research"],"prefix":"10.1007","volume":"43","author":[{"given":"Zahra","family":"Seifi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mozafar","family":"Khazaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malihe","family":"Dayani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sepehr","family":"Zamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonya Baqi","family":"Abdalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Rezakhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"key":"3069_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2024.106007","volume":"100","author":"A Aravindan","year":"2024","unstructured":"Aravindan A, et al. Implications of nanotherapeutic advancements to leverage multi-drug resistant breast cancer: the state-of-the-art review. J Drug Deliv Sci Technol. 2024;100:106007.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3069_CR2","doi-asserted-by":"publisher","first-page":"1561464","DOI":"10.3389\/fmolb.2025.1561464","volume":"12","author":"PK Tiwari","year":"2025","unstructured":"Tiwari PK, et al. Extracellular vesicles in triple-negative breast cancer: current updates, challenges and future prospects. Front Mol Biosci. 2025;12:1561464.","journal-title":"Front Mol Biosci"},{"issue":"7","key":"3069_CR3","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.1016\/j.apsb.2022.02.002","volume":"12","author":"D Sun","year":"2022","unstructured":"Sun D, et al. Why 90% of clinical drug development fails and how to improve it? Acta Pharm Sin B. 2022;12(7):3049\u201362.","journal-title":"Acta Pharm Sin B"},{"issue":"2","key":"3069_CR4","first-page":"114","volume":"6","author":"IW Mak","year":"2014","unstructured":"Mak IW, Evaniew N, Ghert M. Lost in translation: animal models and clinical trials in cancer treatment. Am J Transl Res. 2014;6(2):114\u20138.","journal-title":"Am J Transl Res"},{"key":"3069_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222212200","author":"O Habanjar","year":"2021","unstructured":"Habanjar O, et al. 3D cell culture systems: tumor application, advantages, and disadvantages. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms222212200.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"3069_CR6","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/cas.13155","volume":"108","author":"T Ishiguro","year":"2017","unstructured":"Ishiguro T, et al. Tumor-derived spheroids: relevance to cancer stem cells and clinical applications. Cancer Sci. 2017;108(3):283\u20139.","journal-title":"Cancer Sci"},{"issue":"7","key":"3069_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/pat.6499","volume":"35","author":"P Ebrahimbaygi","year":"2024","unstructured":"Ebrahimbaygi P, et al. Recent advances in scaffold based electrospun for breast cancer research. Polym Adv Technol. 2024;35(7):e6499.","journal-title":"Polym Adv Technol"},{"key":"3069_CR8","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3389\/fbioe.2018.00066","volume":"6","author":"JA Belgodere","year":"2018","unstructured":"Belgodere JA, et al. Engineering breast cancer microenvironments and 3D bioprinting. Front Bioeng Biotechnol. 2018;6:66.","journal-title":"Front Bioeng Biotechnol"},{"issue":"2","key":"3069_CR9","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s10561-024-10136-1","volume":"25","author":"MR Khazaei","year":"2024","unstructured":"Khazaei MR, et al. Decellularized kidney capsule as a three-dimensional scaffold for tissue regeneration. Cell Tissue Bank. 2024;25(2):721\u201334.","journal-title":"Cell Tissue Bank"},{"key":"3069_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2019.119536","volume":"226","author":"I Matai","year":"2020","unstructured":"Matai I, et al. Progress in 3D bioprinting technology for tissue\/organ regenerative engineering. Biomaterials. 2020;226:119536.","journal-title":"Biomaterials"},{"key":"3069_CR11","doi-asserted-by":"publisher","first-page":"8039","DOI":"10.2147\/IJN.S435845","volume":"18","author":"Y Li","year":"2023","unstructured":"Li Y, et al. 3D bioprinting: an important tool for tumor microenvironment research. Int J Nanomedicine. 2023;18:8039\u201357.","journal-title":"Int J Nanomedicine"},{"key":"3069_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26073143","author":"Y Kariya","year":"2025","unstructured":"Kariya Y, Nishita M. Integrins in cancer drug resistance: molecular mechanisms and clinical implications. Int J Mol Sci. 2025. https:\/\/doi.org\/10.3390\/ijms26073143.","journal-title":"Int J Mol Sci"},{"key":"3069_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.actbio.2020.02.006","volume":"106","author":"G Bahcecioglu","year":"2020","unstructured":"Bahcecioglu G, et al. Breast cancer models: engineering the tumor microenvironment. Acta Biomater. 2020;106:1\u201321.","journal-title":"Acta Biomater"},{"key":"3069_CR14","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.addr.2015.10.007","volume":"97","author":"AW Holle","year":"2016","unstructured":"Holle AW, Young JL, Spatz JP. In vitro cancer cell-ECM interactions inform in vivo cancer treatment. Adv Drug Deliv Rev. 2016;97:270\u20139.","journal-title":"Adv Drug Deliv Rev"},{"issue":"8","key":"3069_CR15","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1158\/2159-8290.CD-24-0002","volume":"14","author":"J Prakash","year":"2024","unstructured":"Prakash J, Shaked Y. The interplay between extracellular matrix remodeling and cancer therapeutics. Cancer Discov. 2024;14(8):1375\u201388.","journal-title":"Cancer Discov"},{"issue":"6","key":"3069_CR16","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.7150\/ijbs.108803","volume":"21","author":"F Li","year":"2025","unstructured":"Li F, et al. Unraveling the breast cancer tumor microenvironment: crucial factors influencing natural killer cell function and therapeutic strategies. Int J Biol Sci. 2025;21(6):2606\u201328.","journal-title":"Int J Biol Sci"},{"issue":"1\u20132","key":"3069_CR17","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3121\/cmr.2008.825","volume":"7","author":"AA Onitilo","year":"2009","unstructured":"Onitilo AA, et al. Breast cancer subtypes based on ER\/PR and Her2 expression: comparison of clinicopathologic features and survival. Clin Med Res. 2009;7(1\u20132):4\u201313.","journal-title":"Clin Med Res"},{"issue":"3","key":"3069_CR18","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.ctrv.2013.09.008","volume":"40","author":"P Mallini","year":"2014","unstructured":"Mallini P, et al. Epithelial-to-mesenchymal transition: what is the impact on breast cancer stem cells and drug resistance. Cancer Treat Rev. 2014;40(3):341\u20138.","journal-title":"Cancer Treat Rev"},{"issue":"8","key":"3069_CR19","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1007\/s00330-012-2425-2","volume":"22","author":"JH Youk","year":"2012","unstructured":"Youk JH, et al. Triple-negative invasive breast cancer on dynamic contrast-enhanced and diffusion-weighted MR imaging: comparison with other breast cancer subtypes. Eur Radiol. 2012;22(8):1724\u201334.","journal-title":"Eur Radiol"},{"key":"3069_CR20","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1146\/annurev-bioeng-061008-124949","volume":"11","author":"K Konstantopoulos","year":"2009","unstructured":"Konstantopoulos K, Thomas SN. Cancer cells in transit: the vascular interactions of tumor cells. Annu Rev Biomed Eng. 2009;11:177\u2013202.","journal-title":"Annu Rev Biomed Eng"},{"issue":"2","key":"3069_CR21","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nrc3004","volume":"11","author":"LJ Gay","year":"2011","unstructured":"Gay LJ, Felding-Habermann B. Contribution of platelets to tumour metastasis. Nat Rev Cancer. 2011;11(2):123\u201334.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"3069_CR22","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.molonc.2007.02.004","volume":"1","author":"PA Kenny","year":"2007","unstructured":"Kenny PA, et al. The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression. Mol Oncol. 2007;1(1):84\u201396.","journal-title":"Mol Oncol"},{"issue":"5","key":"3069_CR23","doi-asserted-by":"publisher","first-page":"761","DOI":"10.7150\/jca.17648","volume":"8","author":"M Wang","year":"2017","unstructured":"Wang M, et al. Role of tumor microenvironment in tumorigenesis. J Cancer. 2017;8(5):761\u201373.","journal-title":"J Cancer"},{"key":"3069_CR24","doi-asserted-by":"publisher","first-page":"1568865","DOI":"10.3389\/fmolb.2025.1568865","volume":"12","author":"MR Brogna","year":"2025","unstructured":"Brogna MR, et al. The role of CAFs in therapeutic resistance in triple negative breast cancer: an emerging challenge. Front Mol Biosci. 2025;12:1568865.","journal-title":"Front Mol Biosci"},{"issue":"1","key":"3069_CR25","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/s41420-025-02438-4","volume":"11","author":"MH Ghazimoradi","year":"2025","unstructured":"Ghazimoradi MH, Babashah S. The transcriptional regulators GATA6 and TET1 regulate the TGF-\u03b2 pathway in cancer-associated fibroblasts to promote breast cancer progression. Cell Death Discov. 2025;11(1):164.","journal-title":"Cell Death Discov"},{"key":"3069_CR26","first-page":"316","volume":"42","author":"T Desigaux","year":"2024","unstructured":"Desigaux T, et al. 3D bioprinted breast cancer model reveals stroma-mediated modulation of extracellular matrix and radiosensitivity. Bioact Mater. 2024;42:316\u201327.","journal-title":"Bioact Mater"},{"issue":"7","key":"3069_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202404642","volume":"14","author":"Y Chen","year":"2025","unstructured":"Chen Y, et al. Bioprinted fibroblast mediated heterogeneous tumor microenvironment for studying tumor-stroma interaction and drug screening. Adv Healthc Mater. 2025;14(7):e2404642.","journal-title":"Adv Healthc Mater"},{"issue":"2","key":"3069_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2025.114573","volume":"448","author":"B Guo","year":"2025","unstructured":"Guo B, et al. Runx1 activates the transformation of adipocytes into cancer-associated adipocytes by downregulating Plin1. Exp Cell Res. 2025;448(2):114573.","journal-title":"Exp Cell Res"},{"issue":"3","key":"3069_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202401887","volume":"14","author":"W Jeong","year":"2025","unstructured":"Jeong W, et al. Embedded bioprinting of breast cancer-adipose composite tissue model for patient-specific paracrine interaction analysis. Adv Healthc Mater. 2025;14(3):e2401887.","journal-title":"Adv Healthc Mater"},{"issue":"10","key":"3069_CR30","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1111\/cas.13336","volume":"108","author":"N Maishi","year":"2017","unstructured":"Maishi N, Hida K. Tumor endothelial cells accelerate tumor metastasis. Cancer Sci. 2017;108(10):1921\u20136.","journal-title":"Cancer Sci"},{"issue":"7828","key":"3069_CR31","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41586-020-2774-y","volume":"586","author":"B Tavora","year":"2020","unstructured":"Tavora B, et al. Tumoural activation of TLR3-SLIT2 axis in endothelium drives metastasis. Nature. 2020;586(7828):299\u2013304.","journal-title":"Nature"},{"issue":"4","key":"3069_CR32","doi-asserted-by":"publisher","first-page":"26995","DOI":"10.31083\/FBL26995","volume":"30","author":"Y He","year":"2025","unstructured":"He Y, et al. Role of tumor-associated macrophages in breast cancer immunotherapy. Front Biosci (Landmark Ed). 2025;30(4):26995.","journal-title":"Front Biosci (Landmark Ed)"},{"key":"3069_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-025-03013-5","author":"M Abudula","year":"2025","unstructured":"Abudula M, et al. Macrophages suppress CD8 + T cell cytotoxic function in triple negative breast cancer via VISTA. Br J Cancer. 2025. https:\/\/doi.org\/10.1038\/s41416-025-03013-5.","journal-title":"Br J Cancer"},{"key":"3069_CR34","doi-asserted-by":"publisher","first-page":"1437677","DOI":"10.3389\/fonc.2025.1437677","volume":"15","author":"S Yang","year":"2025","unstructured":"Yang S, et al. Higher baseline platelet and preoperative platelets to lymphocytes ratio was associated with a higher incidence of axillary node pathologic complete response after neoadjuvant chemotherapy in HER2-low breast cancer: a retrospective cohort study. Front Oncol. 2025;15:1437677.","journal-title":"Front Oncol"},{"issue":"12","key":"3069_CR35","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/nrm3904","volume":"15","author":"C Bonnans","year":"2014","unstructured":"Bonnans C, Chou J, Werb Z. Remodelling the extracellular matrix in development and disease. Nat Rev Mol Cell Biol. 2014;15(12):786\u2013801.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"3069_CR36","first-page":"32","volume":"18","author":"MR Khazaei","year":"2023","unstructured":"Khazaei MR, et al. The decellularized calf testis: introducing suitable scaffolds for spermatogenesis studies. Int J Fertil Steril. 2023;18(1):32.","journal-title":"Int J Fertil Steril"},{"issue":"11","key":"3069_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e31589","volume":"10","author":"Z Seifi","year":"2024","unstructured":"Seifi Z, et al. Decellularized tissues as platforms for digestive system cancer models. Heliyon. 2024;10(11):e31589.","journal-title":"Heliyon"},{"key":"3069_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2021.121185","volume":"279","author":"S Patwardhan","year":"2021","unstructured":"Patwardhan S, et al. Ecm stiffness-tuned exosomes drive breast cancer motility through thrombospondin-1. Biomaterials. 2021;279:121185.","journal-title":"Biomaterials"},{"issue":"11","key":"3069_CR39","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1002\/cac2.12364","volume":"42","author":"M Li","year":"2022","unstructured":"Li M, et al. Activation of Piezo1 contributes to matrix stiffness-induced angiogenesis in hepatocellular carcinoma. Cancer Commun (Lond). 2022;42(11):1162\u201384.","journal-title":"Cancer Commun (Lond)"},{"issue":"8","key":"3069_CR40","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1038\/s41563-024-01908-x","volume":"23","author":"BL LeSavage","year":"2024","unstructured":"LeSavage BL, et al. Engineered matrices reveal stiffness-mediated chemoresistance in patient-derived pancreatic cancer organoids. Nat Mater. 2024;23(8):1138\u201349.","journal-title":"Nat Mater"},{"issue":"1","key":"3069_CR41","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1083\/jcb.200807195","volume":"185","author":"F Sabeh","year":"2009","unstructured":"Sabeh F, Shimizu-Hirota R, Weiss SJ. Protease-dependent versus -independent cancer cell invasion programs: three-dimensional amoeboid movement revisited. J Cell Biol. 2009;185(1):11\u20139.","journal-title":"J Cell Biol"},{"issue":"2","key":"3069_CR42","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nrc.2016.123","volume":"17","author":"CD Paul","year":"2017","unstructured":"Paul CD, Mistriotis P, Konstantopoulos K. Cancer cell motility: lessons from migration in confined spaces. Nat Rev Cancer. 2017;17(2):131\u201340.","journal-title":"Nat Rev Cancer"},{"key":"3069_CR43","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.actbio.2025.07.054","volume":"203","author":"B Blanco-Fernandez","year":"2025","unstructured":"Blanco-Fernandez B, et al. A bioprinted breast cancer model using bioinks of decellularized breast tissue for studying cancer stemness, invasion, and drug efficacy. Acta Biomater. 2025;203:306\u201321.","journal-title":"Acta Biomater"},{"issue":"26","key":"3069_CR44","doi-asserted-by":"publisher","first-page":"29467","DOI":"10.1021\/acsami.2c00920","volume":"14","author":"B Blanco-Fernandez","year":"2022","unstructured":"Blanco-Fernandez B, et al. Bioprinting decellularized breast tissue for the development of three-dimensional breast cancer models. ACS Appl Mater Interfaces. 2022;14(26):29467\u201382.","journal-title":"ACS Appl Mater Interfaces"},{"key":"3069_CR45","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/978-3-319-42023-3_3","volume":"936","author":"M Welter","year":"2016","unstructured":"Welter M, Rieger H. Computer simulations of the tumor vasculature: applications to interstitial fluid flow, drug delivery, and oxygen supply. Adv Exp Med Biol. 2016;936:31\u201372.","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"3069_CR46","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.bbcan.2018.12.002","volume":"1871","author":"M Wang","year":"2019","unstructured":"Wang M, et al. Immune checkpoint blockade and its combination therapy with small-molecule inhibitors for cancer treatment. Biochim Biophys Acta Rev Cancer. 2019;1871(2):199\u2013224.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"9","key":"3069_CR47","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.2174\/138955709788922610","volume":"9","author":"A Mar\u00edn-Hern\u00e1ndez","year":"2009","unstructured":"Mar\u00edn-Hern\u00e1ndez A, et al. HIF-1alpha modulates energy metabolism in cancer cells by inducing over-expression of specific glycolytic isoforms. Mini Rev Med Chem. 2009;9(9):1084\u2013101.","journal-title":"Mini Rev Med Chem"},{"issue":"5","key":"3069_CR48","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.cell.2009.01.020","volume":"136","author":"M Mazzone","year":"2009","unstructured":"Mazzone M, et al. Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization. Cell. 2009;136(5):839\u201351.","journal-title":"Cell"},{"key":"3069_CR49","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2020490118","author":"R Wang","year":"2021","unstructured":"Wang R, et al. Hypoxia-inducible factor-dependent ADAM12 expression mediates breast cancer invasion and metastasis. Proc Natl Acad Sci U S A. 2021. https:\/\/doi.org\/10.1073\/pnas.2020490118.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"3069_CR50","doi-asserted-by":"publisher","first-page":"4118","DOI":"10.1038\/s41467-022-31764-9","volume":"13","author":"S Ma","year":"2022","unstructured":"Ma S, et al. Hypoxia induces HIF1\u03b1-dependent epigenetic vulnerability in triple negative breast cancer to confer immune effector dysfunction and resistance to anti-PD-1 immunotherapy. Nat Commun. 2022;13(1):4118.","journal-title":"Nat Commun"},{"issue":"1","key":"3069_CR51","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12943-022-01567-z","volume":"21","author":"R Yang","year":"2022","unstructured":"Yang R, et al. Hypoxia-induced circWSB1 promotes breast cancer progression through destabilizing p53 by interacting with USP10. Mol Cancer. 2022;21(1):88.","journal-title":"Mol Cancer"},{"issue":"4\u20135","key":"3069_CR52","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.semcdb.2005.03.007","volume":"16","author":"H Axelson","year":"2005","unstructured":"Axelson H, et al. Hypoxia-induced dedifferentiation of tumor cells\u2013a mechanism behind heterogeneity and aggressiveness of solid tumors. Semin Cell Dev Biol. 2005;16(4\u20135):554\u201363.","journal-title":"Semin Cell Dev Biol"},{"issue":"3","key":"3069_CR53","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.celrep.2018.12.090","volume":"26","author":"EM Langer","year":"2019","unstructured":"Langer EM, et al. Modeling tumor phenotypes in vitro with three-dimensional bioprinting. Cell Rep. 2019;26(3):608-623.e6.","journal-title":"Cell Rep"},{"issue":"1","key":"3069_CR54","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s12885-019-5449-z","volume":"19","author":"HY Smeland","year":"2019","unstructured":"Smeland HY, et al. Stromal integrin \u03b111-deficiency reduces interstitial fluid pressure and perturbs collagen structure in triple-negative breast xenograft tumors. BMC Cancer. 2019;19(1):234.","journal-title":"BMC Cancer"},{"issue":"4","key":"3069_CR55","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/BF03187139","volume":"1","author":"SD Nathanson","year":"1994","unstructured":"Nathanson SD, Nelson L. Interstitial fluid pressure in breast cancer, benign breast conditions, and breast parenchyma. Ann Surg Oncol. 1994;1(4):333\u20138.","journal-title":"Ann Surg Oncol"},{"key":"3069_CR56","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/141747","volume":"2014","author":"JM Zarzynska","year":"2014","unstructured":"Zarzynska JM. Two faces of TGF-beta1 in breast cancer. Mediators Inflamm. 2014;2014:141747.","journal-title":"Mediators Inflamm"},{"issue":"1","key":"3069_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/jir.2014.0026","volume":"35","author":"M Esquivel-Vel\u00e1zquez","year":"2015","unstructured":"Esquivel-Vel\u00e1zquez M, et al. The role of cytokines in breast cancer development and progression. J Interferon Cytokine Res. 2015;35(1):1\u201316.","journal-title":"J Interferon Cytokine Res"},{"issue":"1","key":"3069_CR58","first-page":"30","volume":"7","author":"E Sheikhpour","year":"2018","unstructured":"Sheikhpour E, et al. A survey on the role of interleukin-10 in breast cancer: a narrative. Rep Biochem Mol Biol. 2018;7(1):30\u20137.","journal-title":"Rep Biochem Mol Biol"},{"issue":"6","key":"3069_CR59","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s12032-025-02737-x","volume":"42","author":"M Amiri","year":"2025","unstructured":"Amiri M, et al. Three-dimensional in vitro models in head and neck cancer: current trends and applications. Med Oncol. 2025;42(6):194.","journal-title":"Med Oncol"},{"issue":"10","key":"3069_CR60","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1172\/JCI28828","volume":"116","author":"G Gallina","year":"2006","unstructured":"Gallina G, et al. Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells. J Clin Invest. 2006;116(10):2777\u201390.","journal-title":"J Clin Invest"},{"issue":"2","key":"3069_CR61","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1053\/j.seminoncol.2014.02.003","volume":"41","author":"CM Diaz-Montero","year":"2014","unstructured":"Diaz-Montero CM, Finke J, Montero AJ. Myeloid-derived suppressor cells in cancer: therapeutic, predictive, and prognostic implications. Semin Oncol. 2014;41(2):174\u201384.","journal-title":"Semin Oncol"},{"issue":"5","key":"3069_CR62","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.7150\/thno.90627","volume":"14","author":"CK Honda","year":"2024","unstructured":"Honda CK, et al. Cancer-associated fibroblast spatial heterogeneity and EMILIN1 expression in the tumor microenvironment modulate TGF-\u03b2 activity and CD8(+) T-cell infiltration in breast cancer. Theranostics. 2024;14(5):1873\u201385.","journal-title":"Theranostics"},{"key":"3069_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.659996","volume":"12","author":"S SenGupta","year":"2021","unstructured":"SenGupta S, et al. Triple-negative breast cancer cells recruit neutrophils by secreting TGF-\u03b2 and CXCR2 ligands. Front Immunol. 2021;12:659996.","journal-title":"Front Immunol"},{"key":"3069_CR64","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23126806","author":"M Park","year":"2022","unstructured":"Park M, et al. Breast cancer metastasis: mechanisms and therapeutic implications. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23126806.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"3069_CR65","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/s41551-019-0400-9","volume":"3","author":"CL Yankaskas","year":"2019","unstructured":"Yankaskas CL, et al. A microfluidic assay for the quantification of the metastatic propensity of breast cancer specimens. Nat Biomed Eng. 2019;3(6):452\u201365.","journal-title":"Nat Biomed Eng"},{"issue":"5","key":"3069_CR66","doi-asserted-by":"publisher","first-page":"R59","DOI":"10.1186\/bcr1610","volume":"8","author":"C Sheridan","year":"2006","unstructured":"Sheridan C, et al. CD44+\/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis. Breast Cancer Res. 2006;8(5):R59.","journal-title":"Breast Cancer Res"},{"issue":"46","key":"3069_CR67","doi-asserted-by":"publisher","first-page":"75571","DOI":"10.18632\/oncotarget.12289","volume":"7","author":"I Holen","year":"2016","unstructured":"Holen I, et al. IL-1 drives breast cancer growth and bone metastasis in vivo. Oncotarget. 2016;7(46):75571\u201384.","journal-title":"Oncotarget"},{"key":"3069_CR68","doi-asserted-by":"publisher","DOI":"10.1088\/1758-5090\/ac925a","author":"M Dey","year":"2022","unstructured":"Dey M, et al. Biofabrication of 3D breast cancer models for dissecting the cytotoxic response of human T cells expressing engineered MAIT cell receptors. Biofabrication. 2022. https:\/\/doi.org\/10.1088\/1758-5090\/ac925a.","journal-title":"Biofabrication"},{"issue":"4","key":"3069_CR69","first-page":"266","volume":"32","author":"K Duval","year":"2017","unstructured":"Duval K, et al. Modeling physiological events in 2D vs. 3D cell culture. Physiology (Bethesda). 2017;32(4):266\u201377.","journal-title":"Physiology (Bethesda)"},{"issue":"Pt 13","key":"3069_CR70","first-page":"3015","volume":"125","author":"BM Baker","year":"2012","unstructured":"Baker BM, Chen CS. Deconstructing the third dimension: how 3D culture microenvironments alter cellular cues. J Cell Sci. 2012;125(Pt 13):3015\u201324.","journal-title":"J Cell Sci"},{"key":"3069_CR71","doi-asserted-by":"publisher","DOI":"10.3390\/cells14120882","author":"T Cao","year":"2025","unstructured":"Cao T, Warren CR. From 2D myotube cultures to 3D engineered skeletal muscle constructs: a comprehensive review of in vitro skeletal muscle models and disease modeling applications. Cells. 2025. https:\/\/doi.org\/10.3390\/cells14120882.","journal-title":"Cells"},{"issue":"4","key":"3069_CR72","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1089\/adt.2014.573","volume":"12","author":"R Edmondson","year":"2014","unstructured":"Edmondson R, et al. Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors. Assay Drug Dev Technol. 2014;12(4):207\u201318.","journal-title":"Assay Drug Dev Technol"},{"issue":"28","key":"3069_CR73","doi-asserted-by":"publisher","first-page":"6626","DOI":"10.1016\/j.biomaterials.2012.05.070","volume":"33","author":"K Kolind","year":"2012","unstructured":"Kolind K, et al. Guidance of stem cell fate on 2D patterned surfaces. Biomaterials. 2012;33(28):6626\u201333.","journal-title":"Biomaterials"},{"key":"3069_CR74","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3389\/fmolb.2020.00033","volume":"7","author":"C Jensen","year":"2020","unstructured":"Jensen C, Teng Y. Is it time to start transitioning from 2D to 3D cell culture? Front Mol Biosci. 2020;7:33.","journal-title":"Front Mol Biosci"},{"key":"3069_CR75","doi-asserted-by":"publisher","first-page":"5395","DOI":"10.2147\/OTT.S249756","volume":"13","author":"Z Huang","year":"2020","unstructured":"Huang Z, Yu P, Tang J. Characterization of triple-negative breast cancer MDA-MB-231 cell spheroid model. Onco Targets Ther. 2020;13:5395\u2013405.","journal-title":"Onco Targets Ther"},{"issue":"5","key":"3069_CR76","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1021\/acs.jnatprod.2c00804","volume":"86","author":"CL Roberge","year":"2023","unstructured":"Roberge CL, et al. Sophorolipid candidates demonstrate cytotoxic efficacy against 2D and 3D breast cancer models. J Nat Prod. 2023;86(5):1159\u201370.","journal-title":"J Nat Prod"},{"issue":"1","key":"3069_CR77","doi-asserted-by":"publisher","first-page":"7259","DOI":"10.1038\/s41598-021-86664-7","volume":"11","author":"E Koedoot","year":"2021","unstructured":"Koedoot E, et al. Differential reprogramming of breast cancer subtypes in 3D cultures and implications for sensitivity to targeted therapy. Sci Rep. 2021;11(1):7259.","journal-title":"Sci Rep"},{"key":"3069_CR78","doi-asserted-by":"publisher","DOI":"10.3390\/bioengineering12020147","author":"M Szostakowska-Rodzo\u015b","year":"2025","unstructured":"Szostakowska-Rodzo\u015b M, et al. Plasticity of expression of stem cell and EMT markers in breast cancer cells in 2D and 3D culture depend on the spatial parameters of cell growth; mathematical modeling of mechanical stress in cell culture in relation to ECM stiffness. Bioengineering (Basel). 2025. https:\/\/doi.org\/10.3390\/bioengineering12020147.","journal-title":"Bioengineering (Basel)"},{"key":"3069_CR79","doi-asserted-by":"publisher","DOI":"10.1088\/1758-5090\/ad2b06","author":"A Kurzyk","year":"2024","unstructured":"Kurzyk A, et al. 3D modeling of normal skin and cutaneous squamous cell carcinoma. A comparative study in 2D cultures, spheroids, and 3D bioprinted systems. Biofabrication. 2024. https:\/\/doi.org\/10.1088\/1758-5090\/ad2b06.","journal-title":"Biofabrication"},{"issue":"10","key":"3069_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e20475","volume":"9","author":"BX Wu","year":"2023","unstructured":"Wu BX, et al. Application of three-dimensional (3D) bioprinting in anti-cancer therapy. Heliyon. 2023;9(10):e20475.","journal-title":"Heliyon"},{"key":"3069_CR81","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-020-0121-2","volume":"4","author":"P Datta","year":"2020","unstructured":"Datta P, et al. 3D bioprinting for reconstituting the cancer microenvironment. NPJ Precis Oncol. 2020;4:18.","journal-title":"NPJ Precis Oncol"},{"key":"3069_CR82","doi-asserted-by":"publisher","first-page":"1610996","DOI":"10.3389\/pore.2023.1610996","volume":"29","author":"D Sztankovics","year":"2023","unstructured":"Sztankovics D, et al. 3D bioprinting and the revolution in experimental cancer model systems-a review of developing new models and experiences with in vitro 3D bioprinted breast cancer tissue-mimetic structures. Pathol Oncol Res. 2023;29:1610996.","journal-title":"Pathol Oncol Res"},{"issue":"4","key":"3069_CR83","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.biotechadv.2015.12.011","volume":"34","author":"C Mandrycky","year":"2016","unstructured":"Mandrycky C, et al. 3D bioprinting for engineering complex tissues. Biotechnol Adv. 2016;34(4):422\u201334.","journal-title":"Biotechnol Adv"},{"key":"3069_CR84","doi-asserted-by":"publisher","DOI":"10.3390\/jfb16050158","author":"AV Singh","year":"2025","unstructured":"Singh AV, et al. Bioinspired soft machines: engineering nature\u2019s grace into future innovations. J Funct Biomater. 2025. https:\/\/doi.org\/10.3390\/jfb16050158.","journal-title":"J Funct Biomater"},{"issue":"35","key":"3069_CR85","doi-asserted-by":"publisher","first-page":"11724","DOI":"10.1021\/acssuschemeng.1c02589","volume":"9","author":"AV Singh","year":"2021","unstructured":"Singh AV, et al. Evaluating particle emissions and toxicity of 3D pen printed filaments with metal nanoparticles as additives. In vitro and in silico discriminant function analysis. ACS Sustain Chem Eng. 2021;9(35):11724\u201337.","journal-title":"ACS Sustain Chem Eng"},{"issue":"2","key":"3069_CR86","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s10561-021-09936-6","volume":"23","author":"S Gupta","year":"2022","unstructured":"Gupta S, Bit A. 3D bioprinting in tissue engineering and regenerative medicine. Cell Tissue Bank. 2022;23(2):199\u2013212.","journal-title":"Cell Tissue Bank"},{"issue":"10","key":"3069_CR87","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.18240\/ijo.2023.10.21","volume":"16","author":"S Al-Atawi","year":"2023","unstructured":"Al-Atawi S. Three-dimensional bioprinting in ophthalmic care. Int J Ophthalmol. 2023;16(10):1702\u201311.","journal-title":"Int J Ophthalmol"},{"key":"3069_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2025.101449","volume":"31","author":"X Mei","year":"2025","unstructured":"Mei X, et al. A bioprinted animal patient-derived breast cancer model for anti-cancer drug screening. Mater Today Bio. 2025;31:101449.","journal-title":"Mater Today Bio"},{"key":"3069_CR89","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24087116","author":"E Fr\u00f6hlich","year":"2023","unstructured":"Fr\u00f6hlich E. The variety of 3D breast cancer models for the study of tumor physiology and drug screening. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24087116.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"3069_CR90","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1039\/C7BM00765E","volume":"6","author":"PS Gungor-Ozkerim","year":"2018","unstructured":"Gungor-Ozkerim PS, et al. Bioinks for 3d bioprinting: an overview. Biomater Sci. 2018;6(5):915\u201346.","journal-title":"Biomater Sci"},{"issue":"1","key":"3069_CR91","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1166\/jnn.2014.8747","volume":"14","author":"S Hassan","year":"2014","unstructured":"Hassan S, Singh AV. Biophysicochemical perspective of nanoparticle compatibility: a critically ignored parameter in nanomedicine. J Nanosci Nanotechnol. 2014;14(1):402\u201314.","journal-title":"J Nanosci Nanotechnol"},{"key":"3069_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2025.101551","volume":"31","author":"S Chen","year":"2025","unstructured":"Chen S, et al. 3D bioprinting technology innovation in female reproductive system. Mater Today Bio. 2025;31:101551.","journal-title":"Mater Today Bio"},{"key":"3069_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2025.123174","volume":"318","author":"K Roshanbinfar","year":"2025","unstructured":"Roshanbinfar K, et al. Enhancing biofabrication: Shrink-resistant collagen-hyaluronan composite hydrogel for tissue engineering and 3D bioprinting applications. Biomaterials. 2025;318:123174.","journal-title":"Biomaterials"},{"key":"3069_CR94","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15010261","author":"N Bock","year":"2023","unstructured":"Bock N, et al. GelMA, click-chemistry gelatin and bioprinted polyethylene glycol-based hydrogels as 3D ex vivo drug testing platforms for patient-derived breast cancer organoids. Pharmaceutics. 2023. https:\/\/doi.org\/10.3390\/pharmaceutics15010261.","journal-title":"Pharmaceutics"},{"key":"3069_CR95","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3389\/fbioe.2019.00217","volume":"7","author":"LJ Bray","year":"2019","unstructured":"Bray LJ, Hutmacher DW, Bock N. Addressing patient specificity in the engineering of tumor models. Front Bioeng Biotechnol. 2019;7:217.","journal-title":"Front Bioeng Biotechnol"},{"issue":"1","key":"3069_CR96","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/s41392-023-01453-0","volume":"8","author":"C Li","year":"2023","unstructured":"Li C, et al. Extracellular matrix-derived mechanical force governs breast cancer cell stemness and quiescence transition through integrin-DDR signaling. Signal Transduct Target Ther. 2023;8(1):247.","journal-title":"Signal Transduct Target Ther"},{"issue":"9","key":"3069_CR97","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1631\/jzus.B2300840","volume":"25","author":"Y Shu","year":"2024","unstructured":"Shu Y, et al. Three-dimensional breast cancer tumor models based on natural hydrogels: a review. J Zhejiang Univ Sci B. 2024;25(9):736\u201355.","journal-title":"J Zhejiang Univ Sci B"},{"issue":"1","key":"3069_CR98","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13058-020-01321-7","volume":"22","author":"KF Ruud","year":"2020","unstructured":"Ruud KF, et al. Distinct phenotypes of cancer cells on tissue matrix gel. Breast Cancer Res. 2020;22(1):82.","journal-title":"Breast Cancer Res"},{"issue":"1","key":"3069_CR99","doi-asserted-by":"publisher","first-page":"630","DOI":"10.18063\/ijb.v9i1.630","volume":"9","author":"J Xu","year":"2023","unstructured":"Xu J, et al. A 3D bioprinted tumor model fabricated with gelatin\/sodium alginate\/decellularized extracellular matrix bioink. Int J Bioprint. 2023;9(1):630.","journal-title":"Int J Bioprint"},{"key":"3069_CR100","doi-asserted-by":"publisher","DOI":"10.3390\/bioengineering10050522","author":"CE Jackson","year":"2023","unstructured":"Jackson CE, et al. Development of PCL polyHIPE substrates for 3D breast cancer cell culture. Bioengineering (Basel). 2023. https:\/\/doi.org\/10.3390\/bioengineering10050522.","journal-title":"Bioengineering (Basel)"},{"key":"3069_CR101","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117637","volume":"181","author":"L Cui","year":"2024","unstructured":"Cui L, et al. Plant-derived extracellular vesicles release combined with systemic DOX exhibits synergistic effects in 3D bioprinted triple-negative breast cancer. Biomed Pharmacother. 2024;181:117637.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"3069_CR102","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1080\/10837450.2021.1872624","volume":"26","author":"R Augustine","year":"2021","unstructured":"Augustine R, et al. Gelatin-methacryloyl hydrogel based in vitro blood-brain barrier model for studying breast cancer-associated brain metastasis. Pharm Dev Technol. 2021;26(4):490\u2013500.","journal-title":"Pharm Dev Technol"},{"issue":"1","key":"3069_CR103","doi-asserted-by":"publisher","DOI":"10.1063\/5.0166206","volume":"8","author":"JW Davern","year":"2024","unstructured":"Davern JW, et al. Addition of laponite to gelatin methacryloyl bioinks improves the rheological properties and printability to create mechanically tailorable cell culture matrices. APL Bioeng. 2024;8(1):016101.","journal-title":"APL Bioeng"},{"key":"3069_CR104","doi-asserted-by":"publisher","DOI":"10.1088\/1758-5090\/ad17d1","author":"F Rasti Boroojeni","year":"2024","unstructured":"Rasti Boroojeni F, et al. Proteolytic remodeling of 3D bioprinted tumor microenvironments. Biofabrication. 2024. https:\/\/doi.org\/10.1088\/1758-5090\/ad17d1.","journal-title":"Biofabrication"},{"key":"3069_CR105","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40824-018-0122-1","volume":"22","author":"J Gopinathan","year":"2018","unstructured":"Gopinathan J, Noh I. Recent trends in bioinks for 3D printing. Biomater Res. 2018;22:11.","journal-title":"Biomater Res"},{"key":"3069_CR106","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jconrel.2021.03.026","volume":"333","author":"M Sharifi","year":"2021","unstructured":"Sharifi M, et al. 3D bioprinting of engineered breast cancer constructs for personalized and targeted cancer therapy. J Control Release. 2021;333:91\u2013106.","journal-title":"J Control Release"},{"issue":"1","key":"3069_CR107","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13058-018-1045-4","volume":"20","author":"JA Reid","year":"2018","unstructured":"Reid JA, et al. Consistent and reproducible cultures of large-scale 3D mammary epithelial structures using an accessible bioprinting platform. Breast Cancer Res. 2018;20(1):122.","journal-title":"Breast Cancer Res"},{"issue":"2","key":"3069_CR108","doi-asserted-by":"publisher","DOI":"10.1088\/1758-5090\/aafc49","volume":"11","author":"S Swaminathan","year":"2019","unstructured":"Swaminathan S, et al. Bioprinting of 3D breast epithelial spheroids for human cancer models. Biofabrication. 2019;11(2):025003.","journal-title":"Biofabrication"},{"key":"3069_CR109","doi-asserted-by":"publisher","DOI":"10.3390\/cells10040803","author":"H Horder","year":"2021","unstructured":"Horder H, et al. Bioprinting and differentiation of adipose-derived stromal cell spheroids for a 3D breast cancer-adipose tissue model. Cells. 2021. https:\/\/doi.org\/10.3390\/cells10040803.","journal-title":"Cells"},{"issue":"12","key":"3069_CR110","doi-asserted-by":"publisher","first-page":"4401","DOI":"10.1021\/acsbiomaterials.8b01277","volume":"4","author":"Y Wang","year":"2018","unstructured":"Wang Y, et al. 3D bioprinting of breast cancer models for drug resistance study. ACS Biomater Sci Eng. 2018;4(12):4401\u201311.","journal-title":"ACS Biomater Sci Eng"},{"issue":"37","key":"3069_CR111","doi-asserted-by":"publisher","first-page":"5512","DOI":"10.1002\/adma.201501729","volume":"27","author":"JM Grolman","year":"2015","unstructured":"Grolman JM, et al. Rapid 3D extrusion of synthetic tumor microenvironments. Adv Mater. 2015;27(37):5512\u20137.","journal-title":"Adv Mater"},{"key":"3069_CR112","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ymeth.2020.04.003","volume":"190","author":"T Liu","year":"2021","unstructured":"Liu T, et al. Investigating lymphangiogenesis in a sacrificially bioprinted volumetric model of breast tumor tissue. Methods. 2021;190:72\u20139.","journal-title":"Methods"},{"key":"3069_CR113","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.139056","volume":"290","author":"J Zhu","year":"2025","unstructured":"Zhu J, et al. A coaxial 3D bioprinted hybrid vascular scaffold based on decellularized extracellular matrix\/nano clay\/sodium alginate bioink. Int J Biol Macromol. 2025;290:139056.","journal-title":"Int J Biol Macromol"},{"key":"3069_CR114","doi-asserted-by":"publisher","DOI":"10.1088\/1758-5090\/add20f","author":"MB Buchholz","year":"2025","unstructured":"Buchholz MB, et al. Development of a bioreactor and volumetric bioprinting protocol to enable perfused culture of biofabricated human epithelial mammary ducts and endothelial constructs. Biofabrication. 2025. https:\/\/doi.org\/10.1088\/1758-5090\/add20f.","journal-title":"Biofabrication"},{"key":"3069_CR115","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23137444","author":"T Dank\u00f3","year":"2022","unstructured":"Dank\u00f3 T, et al. Characterisation of 3D bioprinted human breast cancer model for in vitro drug and metabolic targeting. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23137444.","journal-title":"Int J Mol Sci"},{"key":"3069_CR116","doi-asserted-by":"publisher","first-page":"1390708","DOI":"10.3389\/fbioe.2024.1390708","volume":"12","author":"L Cui","year":"2024","unstructured":"Cui L, et al. Plant-derived extracellular nanovesicles: a promising biomedical approach for effective targeting of triple negative breast cancer cells. Front Bioeng Biotechnol. 2024;12:1390708.","journal-title":"Front Bioeng Biotechnol"},{"issue":"7","key":"3069_CR117","doi-asserted-by":"publisher","first-page":"3584","DOI":"10.62347\/VNWH9165","volume":"14","author":"I Janu\u0161kevi\u010dien\u0117","year":"2024","unstructured":"Janu\u0161kevi\u010dien\u0117 I, Petrikait\u0117 V. Exploring doxorubicin transport in 2D and 3D models of MDA-MB-231 sublines: impact of hypoxia and cellular heterogeneity on doxorubicin accumulation in cells. Am J Cancer Res. 2024;14(7):3584\u201399.","journal-title":"Am J Cancer Res"},{"issue":"21","key":"3069_CR118","doi-asserted-by":"publisher","first-page":"27151","DOI":"10.1021\/acsami.4c04135","volume":"16","author":"P Gonz\u00e1lez-Callejo","year":"2024","unstructured":"Gonz\u00e1lez-Callejo P, et al. 3D bioprinted tumor-stroma models of triple-negative breast cancer stem cells for preclinical targeted therapy evaluation. ACS Appl Mater Interfaces. 2024;16(21):27151\u201363.","journal-title":"ACS Appl Mater Interfaces"},{"key":"3069_CR119","doi-asserted-by":"publisher","DOI":"10.3390\/polym10090961","author":"HS Kim","year":"2018","unstructured":"Kim HS, Lee DY. Near-infrared-responsive cancer photothermal and photodynamic therapy using gold nanoparticles. Polymers. 2018. https:\/\/doi.org\/10.3390\/polym10090961.","journal-title":"Polymers"},{"issue":"9","key":"3069_CR120","doi-asserted-by":"publisher","first-page":"7979","DOI":"10.1021\/acsnano.3c00891","volume":"17","author":"M Overchuk","year":"2023","unstructured":"Overchuk M, et al. Photodynamic and photothermal therapies: synergy opportunities for nanomedicine. ACS Nano. 2023;17(9):7979\u20138003.","journal-title":"ACS Nano"},{"issue":"6","key":"3069_CR121","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1039\/D4NR05026F","volume":"17","author":"G Perini","year":"2025","unstructured":"Perini G, et al. Impact of different 2D materials on the efficacy of photothermal and photodynamic therapy in 3D-bioprinted breast cancer. Nanoscale. 2025;17(6):3221\u201335.","journal-title":"Nanoscale"},{"issue":"18","key":"3069_CR122","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202100636","volume":"10","author":"KH Nam","year":"2021","unstructured":"Nam KH, et al. Quantitative photothermal characterization with bioprinted 3D complex tissue constructs for early-stage breast cancer therapy using gold nanorods. Adv Healthc Mater. 2021;10(18):e2100636.","journal-title":"Adv Healthc Mater"},{"key":"3069_CR123","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.actbio.2019.06.017","volume":"95","author":"PA Mollica","year":"2019","unstructured":"Mollica PA, et al. 3D bioprinted mammary organoids and tumoroids in human mammary derived ECM hydrogels. Acta Biomater. 2019;95:201\u201313.","journal-title":"Acta Biomater"},{"key":"3069_CR124","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.actbio.2014.12.008","volume":"14","author":"W Zhu","year":"2015","unstructured":"Zhu W, et al. Engineering a biomimetic three-dimensional nanostructured bone model for breast cancer bone metastasis study. Acta Biomater. 2015;14:164\u201374.","journal-title":"Acta Biomater"},{"issue":"31","key":"3069_CR125","doi-asserted-by":"publisher","DOI":"10.1088\/0957-4484\/27\/31\/315103","volume":"27","author":"W Zhu","year":"2016","unstructured":"Zhu W, et al. A 3d printed nano bone matrix for characterization of breast cancer cell and osteoblast interactions. Nanotechnology. 2016;27(31):315103.","journal-title":"Nanotechnology"},{"issue":"1","key":"3069_CR126","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.slast.2021.10.002","volume":"27","author":"M Engel","year":"2022","unstructured":"Engel M, et al. Enabling high throughput drug discovery in 3D cell cultures through a novel bioprinting workflow. SLAS Technol. 2022;27(1):32\u20138.","journal-title":"SLAS Technol"},{"issue":"20","key":"3069_CR127","doi-asserted-by":"publisher","first-page":"5876","DOI":"10.1039\/D2BM00651K","volume":"10","author":"M Jung","year":"2022","unstructured":"Jung M, et al. A high-throughput 3d bioprinted cancer cell migration and invasion model with versatile and broad biological applicability. Biomater Sci. 2022;10(20):5876\u201387.","journal-title":"Biomater Sci"},{"issue":"24","key":"3069_CR128","doi-asserted-by":"publisher","first-page":"28389","DOI":"10.1021\/acsami.2c07492","volume":"14","author":"A Nanou","year":"2022","unstructured":"Nanou A, et al. 3D culture modeling of metastatic breast cancer cells in additive manufactured scaffolds. ACS Appl Mater Interfaces. 2022;14(24):28389\u2013402.","journal-title":"ACS Appl Mater Interfaces"},{"key":"3069_CR129","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3389\/fbioe.2020.00082","volume":"8","author":"A Campbell","year":"2020","unstructured":"Campbell A, et al. Thermal bioprinting causes ample alterations of expression of LUCAT1, IL6, CCL26, and NRN1L genes and massive phosphorylation of critical oncogenic drug resistance pathways in breast cancer cells. Front Bioeng Biotechnol. 2020;8:82.","journal-title":"Front Bioeng Biotechnol"},{"issue":"1","key":"3069_CR130","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/s41598-020-79325-8","volume":"11","author":"A Gebeyehu","year":"2021","unstructured":"Gebeyehu A, et al. Polysaccharide hydrogel based 3D printed tumor models for chemotherapeutic drug screening. Sci Rep. 2021;11(1):372.","journal-title":"Sci Rep"},{"key":"3069_CR131","doi-asserted-by":"publisher","DOI":"10.1088\/1758-5090\/abdb87","author":"S Flores-Torres","year":"2021","unstructured":"Flores-Torres S, et al. Alginate-gelatin-Matrigel hydrogels enable the development and multigenerational passaging of patient-derived 3D bioprinted cancer spheroid models. Biofabrication. 2021. https:\/\/doi.org\/10.1088\/1758-5090\/abdb87.","journal-title":"Biofabrication"},{"issue":"1","key":"3069_CR132","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1186\/s12885-025-14187-9","volume":"25","author":"E Anwar","year":"2025","unstructured":"Anwar E, et al. De novo bone metastasis in breast cancer: tumor biology and survival outcomes in a retrospective study from Pakistan. BMC Cancer. 2025;25(1):1074.","journal-title":"BMC Cancer"},{"issue":"44","key":"3069_CR133","doi-asserted-by":"publisher","first-page":"30017","DOI":"10.1021\/acsami.6b10673","volume":"8","author":"X Zhou","year":"2016","unstructured":"Zhou X, et al. 3D bioprinting a cell-laden bone matrix for breast cancer metastasis study. ACS Appl Mater Interfaces. 2016;8(44):30017\u201326.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"2","key":"3069_CR134","doi-asserted-by":"publisher","DOI":"10.1088\/1758-5090\/aa6bad","volume":"9","author":"BT Vinson","year":"2017","unstructured":"Vinson BT, et al. Laser direct-write based fabrication of a spatially-defined, biomimetic construct as a potential model for breast cancer cell invasion into adipose tissue. Biofabrication. 2017;9(2):025013.","journal-title":"Biofabrication"},{"key":"3069_CR135","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.breast.2022.08.010","volume":"66","author":"M Arnold","year":"2022","unstructured":"Arnold M, et al. Current and future burden of breast cancer: global statistics for 2020 and 2040. Breast. 2022;66:15\u201323.","journal-title":"Breast"},{"issue":"3","key":"3069_CR136","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/SAP.0000000000002664","volume":"87","author":"H Masoomi","year":"2021","unstructured":"Masoomi H, et al. Autologous breast reconstruction trends in the United States: using the nationwide inpatient sample database. Ann Plast Surg. 2021;87(3):242\u20137.","journal-title":"Ann Plast Surg"},{"issue":"3","key":"3069_CR137","doi-asserted-by":"publisher","DOI":"10.1097\/GOX.0000000000004180","volume":"10","author":"JM Broyles","year":"2022","unstructured":"Broyles JM, et al. Implant-based versus autologous reconstruction after mastectomy for breast cancer: a systematic review and meta-analysis. Plast Reconstr Surg Glob Open. 2022;10(3):e4180.","journal-title":"Plast Reconstr Surg Glob Open"},{"issue":"2","key":"3069_CR138","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s10549-018-5018-1","volume":"173","author":"MM Jonczyk","year":"2019","unstructured":"Jonczyk MM, et al. Surgical trends in breast cancer: a rise in novel operative treatment options over a 12 year analysis. Breast Cancer Res Treat. 2019;173(2):267\u201374.","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"3069_CR139","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1111\/tbj.13428","volume":"25","author":"BV Manyam","year":"2019","unstructured":"Manyam BV, et al. Long-term complications and reconstruction failures in previously radiated breast cancer patients receiving salvage mastectomy with autologous reconstruction or tissue expander\/implant-based reconstruction. Breast J. 2019;25(6):1071\u20138.","journal-title":"Breast J"},{"issue":"1","key":"3069_CR140","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/SLA.0000000000002990","volume":"269","author":"CJ Coroneos","year":"2019","unstructured":"Coroneos CJ, et al. US FDA breast implant postapproval studies: long-term outcomes in 99,993 patients. Ann Surg. 2019;269(1):30\u20136.","journal-title":"Ann Surg"},{"issue":"3","key":"3069_CR141","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1089\/ten.teb.2016.0303","volume":"23","author":"LE Visscher","year":"2017","unstructured":"Visscher LE, et al. Breast augmentation and reconstruction from a regenerative medicine point of view: state of the art and future perspectives. Tissue Eng Part B Rev. 2017;23(3):281\u201393.","journal-title":"Tissue Eng Part B Rev"},{"key":"3069_CR142","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2021.641370","volume":"8","author":"X Mu","year":"2021","unstructured":"Mu X, Zhang J, Jiang Y. 3D printing in breast reconstruction: from bench to bed. Front Surg. 2021;8:641370.","journal-title":"Front Surg"},{"key":"3069_CR143","doi-asserted-by":"publisher","DOI":"10.1088\/1758-5090\/adb890","author":"N Hedemann","year":"2025","unstructured":"Hedemann N, et al. Light-based multi-material bioprinting of vascularised adipose tissue for breast fatty tissue engineering. Biofabrication. 2025. https:\/\/doi.org\/10.1088\/1758-5090\/adb890.","journal-title":"Biofabrication"},{"key":"3069_CR144","first-page":"12","volume":"12","author":"J Zhang","year":"2018","unstructured":"Zhang J, et al. Computer-assisted 3-dimensional printing technology for immediate breast reconstruction after breast-conserving surgery. Chin J Breast Dis. 2018;12:12\u20136.","journal-title":"Chin J Breast Dis"},{"issue":"9","key":"3069_CR145","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/j.bjps.2017.06.001","volume":"70","author":"ZM Jessop","year":"2017","unstructured":"Jessop ZM, et al. 3D bioprinting for reconstructive surgery: principles, applications and challenges. J Plast Reconstr Aesthet Surg. 2017;70(9):1155\u201370.","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"3069_CR146","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22083971","author":"J Zhang","year":"2021","unstructured":"Zhang J, et al. 3D bioprinting of human tissues: biofabrication, bioinks, and bioreactors. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22083971.","journal-title":"Int J Mol Sci"},{"key":"3069_CR147","doi-asserted-by":"publisher","DOI":"10.3390\/polym17070948","author":"S Liu","year":"2025","unstructured":"Liu S, Jin P. Advances and challenges in 3D bioprinted cancer models: opportunities for personalized medicine and tissue engineering. Polymers. 2025. https:\/\/doi.org\/10.3390\/polym17070948.","journal-title":"Polymers"},{"key":"3069_CR148","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2024.101185","volume":"28","author":"R Byrne","year":"2024","unstructured":"Byrne R, et al. Bioinks and biofabrication techniques for biosensors development: a review. Mater Today Bio. 2024;28:101185.","journal-title":"Mater Today Bio"},{"key":"3069_CR149","first-page":"201","volume":"45","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, et al. Ai-driven 3D bioprinting for regenerative medicine: from bench to bedside. Bioact Mater. 2025;45:201\u201330.","journal-title":"Bioact Mater"},{"issue":"7","key":"3069_CR150","doi-asserted-by":"publisher","first-page":"587","DOI":"10.4155\/fmc-2024-0007","volume":"16","author":"SE Biehn","year":"2024","unstructured":"Biehn SE, et al. Bioprint meets the AI age: development of artificial intelligence-based ADMET models for the drug-discovery platform SAFIRE. Future Med Chem. 2024;16(7):587\u201399.","journal-title":"Future Med Chem"},{"key":"3069_CR151","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2025.115670","volume":"225","author":"D Vaskovich-Koubi","year":"2025","unstructured":"Vaskovich-Koubi D, et al. Patient-derived 3D-bioprinted models of pancreatic cancer: toward personalized therapy and overcoming tumor microenvironment challenges. Adv Drug Deliv Rev. 2025;225:115670.","journal-title":"Adv Drug Deliv Rev"},{"key":"3069_CR152","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.jare.2024.09.011","volume":"74","author":"H Sun","year":"2025","unstructured":"Sun H, et al. Developing patient-derived 3d-bioprinting models of pancreatic cancer. J Adv Res. 2025;74:165\u201374.","journal-title":"J Adv Res"},{"issue":"2","key":"3069_CR153","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202304460","volume":"11","author":"H Sun","year":"2024","unstructured":"Sun H, et al. Prediction of clinical precision chemotherapy by patient-derived 3D bioprinting models of colorectal cancer and its liver metastases. Adv Sci (Weinh). 2024;11(2):e2304460.","journal-title":"Adv Sci (Weinh)"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-03069-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-025-03069-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-03069-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T05:03:06Z","timestamp":1769490186000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-025-03069-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":153,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["3069"],"URL":"https:\/\/doi.org\/10.1007\/s12032-025-03069-6","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"assertion":[{"value":"7 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"During the preparation of this work, the authors used AI to improve the readability and language of the manuscript. After using these services, the authors reviewed and edited the content as needed and take full responsibility for the content of the published article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of generative AI and AI-assisted technologies in the writing process"}}],"article-number":"1"}}